Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Särndahl, E.
Right arrow Articles by Andersson, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Särndahl, E.
Right arrow Articles by Andersson, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Volume 271, Number 25, Issue of June 21, 1996 pp. 15267-15271
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Direct or C5a-induced Activation of Heterotrimeric Gi2 Proteins in Human Neutrophils Is Associated with Interaction between Formyl Peptide Receptors and the Cytoskeleton*

(Received for publication, September 18, 1995, and in revised form, February 21, 1996)

Eva Särndahl Dagger §, Gary M. Bokoch , François Boulay par , Olle Stendahl '' and Tommy Andersson Dagger

From the Departments of Dagger  Cell Biology and '' Medical Microbiology, Linköping University, S-581 85 Linköping, Sweden, the  Departments of Immunology and Cell Biology, Research Institute of Scripps Clinic, La Jolla, California 92037, and par  DBMS/Laboratoire de Biochimie, CEA-Grenoble, 17 rue des Martyrs, 38054 Grenoble Cedex 9, France

ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES


ABSTRACT

The binding of ligands to N-formyl peptide chemoattractant receptors in human neutrophils results in a rapid association of these receptors with a cytoskeletal fraction and a specific activation and release of Gi2 alpha -subunits from this fraction. In the present study we could show that pretreating neutrophils with GDPbeta S prevented the fMet-Leu-Phe-induced association of its receptor with a cytoskeletal fraction and also blocked the release of Gi2 alpha -subunits from the same cytoskeletal fraction. In contrast, direct activation of Gi2 proteins by addition of GTPgamma S or AlF-4 not only caused a release of Gi2 alpha -subunits from the cytoskeleton but also an association of formyl peptide receptors with the cytoskeleton. The receptor for complement fragment 5a, which transduces its signaling through the same Gi2 protein, triggers both a release of Gi2 alpha -subunits from the cytoskeleton fraction and, of even greater interest, an association between formyl peptide receptors and the cytoskeleton. The close relationship between the activation and release of Gi2 alpha -subunits from the cytoskeleton and the association of formyl peptide receptors with the cytoskeleton might, however, not be a matter of protein-protein exchange, since the increased binding of formyl peptide receptors to the cytoskeleton occurs more rapidly than the release of Gi2 alpha -subunits from the cytoskeleton. The present findings suggest a possible mechanism for the initiation of formyl peptide receptor desensitization during neutrophil locomotion.


INTRODUCTION

Human neutrophils are phagocytic cells specialized in the destruction of invading microorganisms. To perform this important role in host defense, these cells emigrate from the blood vessels to the sites of infection. This directed locomotion, as well as other neutrophil responses, is triggered by chemotactic factors, e.g. complement fragment 5a (C5a),1 leukotriene B4, and N-formylated peptides. Many of the receptors for these ligands have been cloned (Boulay et al., 1990; Gerard and Gerard, 1990) and shown to belong to a subclass of small seven-transmembrane-spanning G-protein-coupled receptors (Probst et al., 1992; Prossnitz et al., 1993). Related chemoattractant receptors show a greater degree of homology in their intracellular domains than in their extracellular domains, suggesting that they may have common mechanisms of signal transduction and receptor regulation (Ye et al., 1991). The neutrophil receptor for N-formylated peptides (FPR) is one of the most thoroughly studied chemoattractant receptors (for review, see Murphy, 1994). This receptor is a glycosylated protein with an apparent molecular mass of 50-70 kDa, as estimated by photoaffinity labeling (Tardif et al., 1993; Sengeløv et al., 1994).

To be able to move in a chemotactic gradient, motile cells like the human neutrophil must respond to changes in the concentration of one or probably several stimuli. In part, this is achieved by an adaptive process that results in a blunted response despite the permanent presence of agonists. This process, which is also called desensitization, involves receptor down-regulation by internalization as well as more rapid mechanisms by which components of the signaling pathway are modified. In general, two types of desensitization have been characterized, and these are designated homologous and heterologous (Sibley and Lefkowitz, 1985). Homologous desensitization affects only the receptor system that has been activated by an agonist, whereas heterologous desensitization also inactivates other receptors coupled to the same effector system. Both types of desensitization results in the uncoupling of receptors from their effector enzymes. Several potentially interrelated mechanisms for how the receptor-G-protein interaction are altered when cells get desensitized have been demonstrated and hypothesized (Sibley et al., 1985; McLeish et al., 1989).

Considering the neutrophil FPR, it has previously been suggested that binding to the cytoskeleton is an important step in the desensitization of this receptor to chemotactic peptides (Jesaitis et al., 1984; Jesaitis et al., 1986). In addition to the association of FPRs with the cytoskeleton, a lateral segregation of the FPR from its G-protein has also been observed (Jesaitis et al., 1989; for review, see Jesaitis, 1992). Such segregation could well be a consequence of the N-formyl-L-methionyl-L-leucyl-L-phenylalanine (fMet-Leu-Phe)-induced release of the alpha -subunits of the Gi2 protein (Gi2 alpha -subunits) from the cytoskeleton (Särndahl et al., 1993) and would, as part of the desensitization process, serve to keep the FPR from transducing its signal to its corresponding G-protein. Although both the activation and cellular handling of Gi2 proteins and FPRs are most likely of importance in the desensitization process, it is still unclear whether they are in any way interrelated.

The present study was performed to reveal whether or not the activation and release of Gi2 alpha -subunits from the cytoskeleton and the association of FPRs with the cytoskeleton are interdependent processes. This was done to gain further knowledge about the desensitization of FPRs that is necessary for neutrophil locomotion.


MATERIALS AND METHODS

Chemicals

All reagents used were of an analytical grade. Dextran and Ficoll-Paque were from Pharmacia Biotech (Sollentuna, Sweden), fMet-Leu-Phe was obtained from Sigma, and GDPbeta S and GTPgamma S were both from Boehringer Mannheim (Mannheim, Germany). The peroxidase-conjugated goat anti-rabbit antiserum was obtained from Dako A/S (Glostrup, Denmark), and the enhanced chemiluminescence detection system was from Amersham Int. (Buckinghamshire, U. K.). The affinity purified rabbit anti-FPR antibody was raised against amino acid 340-350 of the carboxyl tail of the human FPR (i.e. the FPR C-terminal peptide; Tardif et al., 1993). The rabbit antiserum R16,17 was raised against a peptide corresponding to the 9-amino acid C-terminal sequence of Gi and was shown to react specifically with Gi2alpha  > Gi1alpha >>  Gi3alpha or Goalpha (Bokoch et al., 1988).

Isolation of Human Neutrophils

Peripheral human blood was obtained from healthy volunteers and collected in heparin-containing vacutainer tubes. After sedimentation on dextran, the neutrophils were isolated according to the method described by Böyum (1968). The obtained cell suspension, which consisted of approximately 98% neutrophils, was washed twice and then resuspended in a calcium-containing medium as described previously (Särndahl et al., 1993). The cells were routinely pretreated with 2.5 mM diisopropyl fluorophosphate for 10 min and then kept on ice pending further processing.

Neutrophil Permeabilization

Neutrophils were electrically permeabilized according to a previously described method (Särndahl et al., 1989; Fällman et al., 1992). The cells were kept on ice and rendered permeable by repeated exposures (150 µs each) to an electrical field of 1.7 kV/cm. After permeabilization, the cells were immediately exposed to stimuli, as indicated in the figure legends.

Preparation of the Cytoskeletal Fractions

Cytoskeletal fractions were prepared using Triton X-100 (TX-100) as described by Särndahl et al. (1989, 1993). The obtained cytoskeletal preparations were washed once, pelleted, and prepared for electrophoresis by resuspending the pellets in a sample buffer previously described (Särndahl et al., 1993).

SDS-PAGE and Immunoblot Detection of FPRs and Gi2 alpha -Subunits

Cytoskeletal preparations were solubilized in sample buffer and boiled for 5 min. Thereafter, the proteins of each sample (1 × 106 cell equivalents per lane) were separated on a 7.5 or 10% SDS-polyacrylamide gel to detect FPRs and Gi2 alpha -subunits, respectively. The proteins were then blotted onto a PVDF membrane as described previously (Särndahl et al., 1993). The membranes were blocked with 5% (w/v) bovine serum albumin in phosphate-buffered saline, pH 7.3, overnight at 4 °C, and then with 0.5% (w/v) dried milk for 30 min at 37 °C. The immunoblotting was performed by exposing the PVDF membranes to the different primary antibodies, after which a peroxidase-conjugated secondary antibody was added and the immune reaction was detected as enhanced chemiluminescence. When using the anti-FPR antibody, control experiments were performed by adding the antibody (1:300 dilution) to the FPR C-terminal peptide against which the antibody had been raised (10 µg/ml) for 24 h at 4 °C. This mixture was then added to the PVDF membrane, and the immune reaction was detected as described above. Densitometric analysis was performed with an UltroScan XL enhanced laser densitometer (LKB, Bromma, Sweden).


RESULTS

Effects of GDPbeta S on the Association of FPRs and Gi2 alpha -Subunits with the Cytoskeleton

In a previous study (Särndahl et al., 1989), we used radiolabeled ligand to detect FPR and found that pretreatment of permeabilized cells with GDPbeta S appeared to prevent the binding of ligand-receptor complexes to the cytoskeleton. However, it is possible that these results actually reflected a decreased binding of the radiolabeled ligand to the receptor and not a true reduction in the binding of the ligand-receptor complex to the cytoskeleton. On the other hand, our original interpretation is supported by the present finding that the association between the FPR and the cytoskeleton was inhibited in GDPbeta S-treated neutrophils, as shown by immunoblot analysis (Fig. 1A). The affinity purified anti-FPR antibody we used detected a rather thin and distinct protein band at approximately 55 kDa, which is somewhat different to the protein band(s) that Sengelphi v et al. (1994) observed as a smear around 50-70 kDa when photolabeling were used. The specificity of the binding of the antibody in the present study was confirmed by the finding that if the anti-FPR antibody was preincubated with the peptide against which the antibody was raised, this resulted in a failure to detect the 55-kDa protein band (data not shown). Although not addressed in the present study, it is possible that the association of FPRs with the cytoskeleton is somehow associated with a structural modification of the receptor. Using the same batch of cells, GDPbeta S was also noted to have an inhibitory effect on the fMet-Leu-Phe-induced release of the 40-kDa Gi2 alpha -subunit from the cytoskeleton (Fig. 1B). Densitometer analysis of these blots revealed that 94 ± 1% (mean ± S.E., n = 4) of the 40-kDa protein band remained associated with the cytoskeletal fraction in GDPbeta S-pretreated neutrophils after fMet-Leu-Phe stimulation in contrast to 23 ± 4% (mean ± S.E., n = 5) when not pretreated with GDPbeta S. Despite the effects of GDPbeta S noted in the presence of fMet-Leu-Phe, GDPbeta S alone was not found to have any effect on the binding of either FPRs or Gi2 alpha -subunits to the cytoskeleton (data not shown).


Fig. 1. Immunoblot analysis of the association of FPRs and Gi2 alpha -subunits with the cytoskeleton in GDPbeta S-pretreated neutrophils. The GDPbeta S pretreatment was carried out as described previously (Särndahl et al., 1989). Immediately after permeabilization, the neutrophils were exposed to 1 mM GDPbeta S for 10 min at 4 °C. The samples were then transferred to a 37 °C water bath, incubated for an additional 10 min, and subsequently stimulated with 20 nM fMet-Leu-Phe for 30 s. The stimulation was stopped by putting the cells on ice and simultaneously adding ice-cold TX-100-containing medium. Neutrophils termed ``unstimulated'' were permeabilized but not treated with GDPbeta S or fMet-Leu-Phe. The 1st and 2nd lanes, respectively, show the cytoskeletal fractions of unstimulated and fMet-Leu-Phe-stimulated GDPbeta S-treated neutrophils; for comparison, the 3rd lane shows the cytoskeletal fraction of fMet-Leu-Phe-stimulated permeabilized cells not treated with GDPbeta S. The proteins were detected with a 1:300 dilution of the anti-FPR antibody (A) and a 1:2500 dilution of the anti-Gi2 alpha -antibody (R16, 17) (B).

Effects of GTPgamma S and AlF-4 on the Association of FPRs and Gi2 alpha -Subunits with the Cytoskeleton

The association of FPRs with the cytoskeleton was further examined by incubating the cells with GTPgamma S or AlF-4 to activate the G-protein in a ligand-independent manner. As shown in Fig. 2A (2nd and 5th lanes), GTPgamma S and AlF-4, respectively, induced an association between the receptor and the cytoskeleton, even in the absence of fMet-Leu-Phe. These effects were quite comparable with the association obtained when using fMet-Leu-Phe alone (Fig. 2A, 3rd and 6th lanes). Parallel immunoblot analysis also confirmed that both GTPgamma S and AlF-4 induced a release of Gi2 alpha -subunits from the cytoskeletal fraction (Fig. 2B, 2nd and 5th lanes) that was quite similar to that observed upon stimulation with fMet-Leu-Phe alone (Fig. 2B, 3rd and 6th lanes, and Fig. 1B). Densitometer analysis revealed that only 22 ± 7 and 26 ± 6% (mean ± S.E., n = 6 and 5) of the 40-kDa protein band remained associated with the cytoskeletal fraction after GTPgamma S- or AlF-4 activation, respectively.


Fig. 2. Effects of GTPgamma S and AlF-4 on the association of FPRs and Gi2 alpha -subunits with the cytoskeleton. Activation with GTPgamma S and AlF-4 was carried out as described previously (Särndahl et al., 1993). Neutrophils were exposed to AlF-4 (10 µM AlCl3 + 20 mM NaF) for 20 min at 37 °C or, immediately after permeabilization, to 100 µM GTPgamma S for 10 min at 4 °C and then transferred to a water bath and incubated at 37 °C for an additional 10 min. The stimulation was stopped by putting the cells on ice and simultaneously adding ice-cold TX-100-containing medium. Unstimulated indicates cytoskeletal fractions of permeabilized or unpermeabilized neutrophils not treated with GTPgamma S or AlF-4 (1st and 4th lanes). 2nd and 5th lanes show the cytoskeletal fractions of GTPgamma S- and AlF-4-treated neutrophils, respectively. For comparison, 3rd and 6th lanes show the cytoskeletal fraction of unpermeabilized fMet-Leu-Phe-stimulated cells. The proteins were detected with a 1:300 dilution of the anti-FPR antibody (A) and a 1:2500 dilution of the anti-Gi2 alpha -antibody (R16,17) (B).

Effects of C5a on the Association of FPRs and Gi2 alpha -Subunits with the Cytoskeleton

The receptor for C5a, which is known to couple to Gi2 proteins, caused a release of Gi2 alpha -subunits from the cytoskeleton (Fig. 3B, 2nd lane) similar to that caused by fMet-Leu-Phe (Fig. 3B, 3rd lane, and Fig. 1B). Densitometer analysis revealed that only 33 ± 5% (mean ± S.E., n = 4) of the 40-kDa protein band remained associated with the cytoskeletal fraction after C5a stimulation. Of even greater interest, C5a stimulation led to an association between FPRs and the cytoskeleton (Fig. 3A, 2nd lane). Since these findings were obtained with a natural ligand that is known to activate Gi2 proteins, they confirm the results gained by direct manipulation of the Gi2 proteins with GTPgamma S and AlF-4 (Fig. 2).


Fig. 3. Immunoblot analysis of the association of FPRs and Gi2 alpha -subunits with the cytoskeleton in C5a-stimulated neutrophils. The cells were preincubated for 5 min at 37 °C and then stimulated with 20 nM C5a for 30 s. The stimulation was stopped by putting the cells on ice and simultaneously adding ice-cold TX-100-containing medium. Neutrophils termed unstimulated were subjected to the 5-min equilibration period at 37 °C but were not stimulated (1st lane). 2nd lane shows the cytoskeletal fractions of C5a-treated neutrophils. For comparison, the 3rd lane shows the cytoskeletal fraction of fMet-Leu-Phe-stimulated cells. The proteins were detected with a 1:300 dilution of the anti-FPR antibody (A) and a 1:2500 dilution of the anti-Gi2 alpha -antibody (R16,17) (B).

Temporal Changes in the Association of FPRs and Gi2 alpha -Subunits with the Cytoskeleton

To examine the kinetics of the release of Gi2 alpha -subunits and the interaction of FPRs with the cytoskeleton, neutrophils were stimulated with fMet-Leu-Phe at 15 °C. At that temperature, the receptor is converted into a high affinity form and becomes associated with the cytoskeletal fraction but is not internalized (Jesaitis et al., 1984; Sklar et al., 1984); in contrast, internalization occurs rapidly at 37 °C (t1/2 15-20 s; Janeczek et al., 1989). Only very few FPRs could be detected in the cytoskeletal fraction of unstimulated neutrophils (Fig. 4A, inset, 1st lane). The fMet-Leu-Phe-induced association of FPR with the cytoskeletal fraction occurred rapidly and then leveled off (Fig. 4A, and inset, 2nd through 4th lanes). Concurrently, the number of 40-kDa Gi2 alpha -subunits associated with the cytoskeletal fraction of unstimulated neutrophils (Fig. 4B, inset, 1st lane) decreased upon stimulation with fMet-Leu-Phe. Comparison of the cellular handling of FPRs and Gi2 alpha -subunits reveals that the fMet-Leu-Phe-induced association of FPRs with the cytoskeleton precedes the release of Gi2 alpha -subunits from the same cellular fraction (Fig. 4).


Fig. 4. Time correlation between the interactions of Gi2 alpha -subunits and FPRs with the cytoskeleton. Neutrophils were preincubated for 5 min at 15 °C and then stimulated with 20 nM fMet-Leu-Phe. At different time points (abscissa), cells were withdrawn and added to ice-cold TX-100-containing medium, as described previously (Särndahl et al., 1989). The graphs show the relative amount of FPR (A) and Gi2 alpha -subunits (B) in the cytoskeletal fractions of fMet-Leu-Phe-stimulated neutrophils, as revealed by densitometric analysis of immunoblots obtained by using either the anti-FPR antibody (a 1:300 dilution) or the anti-Gi2 alpha -antibody R16, 17 (a 1:2500 dilution). Data are given as mean ± S.E. for four separate experiments and expressed as percent of the maximum value for each individual experiment. The insets show representative immunoblots of the cytoskeletal association of both FPRs (A) and Gi2 alpha -subunits (B).


DISCUSSION

Using the immunoblot technique and antibodies directed against the FPR or the Gi2 alpha -subunit, we studied the interdependence of the binding of chemotactic peptide receptors to the cytoskeleton and the activation and release of Gi2 alpha -subunits from the cytoskeleton. Exposing neutrophils to GDPbeta S, a GDP analogue that keeps the G-protein in an inactivated state, prevented the chemotactic peptide-induced release of Gi2 alpha -subunits from the cytoskeletal fraction and also inhibited the association of FPRs with the cytoskeleton. These findings suggest that binding of FPRs to the cytoskeleton is regulated by a G-protein, as previously proposed (Särndahl et al., 1989). In the cited investigation, we used a radiolabeled ligand to detect FPRs when measuring the effects of GDPbeta S; hence, it is possible that the results actually reflect a reduced binding affinity between the ligand and its receptor. This alternative interpretation is based on the fact that both GDPbeta S and GTPgamma S cause a concentration-dependent reduction in the affinity of the FPR for its ligand (Koo et al., 1983; Posner et al., 1994). However, in the present study we employed an immunoblot technique to directly detect the receptor protein itself and also found that GDPbeta S and GTPgamma S affected the FPR cytoskeletal association in completely different ways. We are therefore convinced that the major effect of GDPbeta S, in this context, is to inhibit the association of FPR with the cytoskeleton.

The impaired association of FPR with the cytoskeleton obtained by incubating the cells with GDPbeta S was obtained in the presence of the commonly used ligand fMet-Leu-Phe. On the other hand, and perhaps of greater interest in the present study, both GTPgamma S and AlF-4 were found to induce association of FPRs with the cytoskeleton, even in the absence of any natural FPR ligand (Fig. 2A). This means that association of the FPR with the cytoskeleton requires neither the binding of a natural ligand nor the immediate conformational change that occurs in the receptor as a result of that protein-protein interaction. Furthermore, these findings are in agreement with a regulatory role of G-proteins in the process of FPR cytoskeleton association. The fact that stimulation with either GTPgamma S or AlF-4 triggers an association between FPRs and the cytoskeleton and a parallel release of Gi2 alpha -subunits from the cytoskeleton (Fig. 2B) suggests that the FPR cytoskeletal association might be related to an activation-dependent release of Gi2 alpha -subunits from the cytoskeleton. Analysis of the time dependence of both the binding of FPRs to and the release of Gi2 alpha -subunits from the cytoskeleton (at 15 °C) revealed that the former association of FPRs occurred faster than the latter release of Gi2 alpha -subunits. This suggests that a mechanism more complex than a simple protein-for-protein exchange is involved in the FPR cytoskeletal association; however, such a conclusion might be uncertain due to the difference in number of FPRs and Gi2 alpha -subunits.

In this context, it should be mentioned that receptor phosphorylation is another step that is most likely involved in desensitization of the FPR, as has previously been demonstrated in the visual system (Wilden et al., 1986) and in the beta -adrenergic receptor system (Lefkowitz et al., 1990). This supposition is based on the finding that the FPR in differentiated HL60 cells undergoes phosphorylation soon after stimulation (t1/2 around 1 min, Tardif et al., 1993) and that there is a correlation between the phosphorylation and the desensitization of this receptor (Ali et al., 1993). Recently, it has also been suggested based on in vitro experiments that the FPR might be phosphorylated by a cytosolic kinase that has features similar to those of GRK2, a G-protein-coupled receptor kinase (Prossnitz et al., 1995). The present finding that G-protein activation could be an initial step in the association of FPRs with the cytoskeleton is compatible with the idea that phosphorylation of the FPR is a subsequent step in the desensitization process; this is true because an initial activation of G-proteins is known to activate several downstream protein kinases. A G-protein-induced phosphorylation of the FPR may be required to allow this receptor to become associated with the cytoskeleton and segregated from its Gi2 protein (which at the same time is released from the cytoskeleton). If this is the case, then it is not surprising that desensitization had no effect on the affinity in FPR-G-protein interactions as seen in reconstitution experiments (Klotz and Jesaitis, 1994). Additional experiments are needed, however, to determine whether phosphorylation of FPR precedes or follows the association of FPR with the cytoskeleton.

Desensitization of the N-formyl peptide receptor was demonstrated several years ago in a number of laboratories (Showell et al., 1979; Jesaitis et al., 1986). Notwithstanding, the molecular basis of this process is still unknown, although both homologous and heterologous desensitization appear to be involved (Didsbury et al., 1991; McLeish et al., 1989). Interestingly, Didsbury and co-workers (1991) proposed that a third type of desensitization, referred to as ``class desensitization,'' also exists. These researchers observed that two chemotactic receptors in human neutrophils, namely the receptors for fMet-Leu-Phe and C5a, which are both coupled to the Gi2 protein, are able to desensitize each other but that the alpha 1-adrenergic receptor, which is coupled to a different G-protein (i.e. Gq), is not affected by pre-exposure to either fMet-Leu-Phe or C5a. Our experiments show that the FPR associates with the cytoskeleton not only when it is activated by its ligand but, more importantly, also when it is activated by another chemotactic stimulus, namely C5a. These findings are supported by the fact that the FPR also becomes associated with the cytoskeleton when the Gi2 protein is directly activated by GTPgamma S or AlF-4 in the absence of a ligand. Taken together, these results agree with the idea of class desensitization (Didsbury et al., 1991) and suggest that the FPR can be desensitized by other receptors at the G-protein level. Moreover, in the present study stimulation with C5a released the alpha -subunits of its transducing G-protein (i.e. Gi2 protein) from the cytoskeleton. This finding provides additional support to the hypothesis that cellular segregation of FPRs and Gi2 proteins is an essential part of the mechanism underlying the termination and/or desensitization of FPR signaling properties (Jesaitis et al., 1989; for review see Jesaitis 1992). Furthermore, the previous observation that fMet-Leu-Phe-stimulation causes a selective release of Gi2 alpha -subunits without affecting the association of Gs alpha -subunits to the cytoskeleton (Särndahl et al., 1993) provides at least a partial explanation for the selectivity of class desensitization that is indicated in the model proposed by Didsbury and co-workers (1991).


FOOTNOTES

*   This work was supported by the Swedish Cancer Association (to T. A.), the King Gustav V Memorial Foundation (to T. A., E. S., and O. S.), the Swedish Association for Medical Research (to E. S.), the Swedish Society of Medicine (to E. S.), the Swedish Medical Research Council (to O. S.), the Swedish Association against Rheumatism (to T. A. and O. S.), the Åke Wiberg Foundation (to T. A.), United States Public Health Service Grant GM 39434 (to G. M. B.), Centre National de la Recherche Scientifique (to F. B.), Association pour la Recherche sur le Cancer (to F. B.), and the French Nuclear Agency (to F. B.). The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§   Supported by a postdoctoral fellowship from the Swedish Cancer Foundation. To whom correspondence should be addressed: Dept. of Cell Biology, Faculty of Health Sciences, Linköping University, S-581 85 Linköping, Sweden. Tel.: 46 13 22 39 06; Fax: 46 13 22 41 49.
1   The abbreviations used are: C5a, complement fragment 5a; FPR, formyl peptide receptor; fMet-Leu-Phe, N-formyl-L-methionyl-L-leucyl-L-phenylalanine; G-protein, GTP-binding protein; Gi2 alpha -subunit, alpha -subunit of the Gi2 protein; Gnalpha , alpha -subunit of the Gi2 protein; Gs alpha -subunit, alpha -subunit of the Gs protein; GDPbeta S, guanosine-5'-O-(2-thiodiphosphate); GTPgamma S, guanosine-5'-O-(3-thiotriphosphate); PVDF, polyvinylidene difluoride; TX-100, Triton X-100.

Acknowledgments

We are much indebted to Susanne Thunholm and Pia Druid for expert technical assistance and Patricia Ödman for linguistic revision of the manuscript.


REFERENCES

  1. Ali, H., Richardson, R. M., Tomhave, E. D., Didsbury, J. R., Snyderman, R. (1993) J. Biol. Chem. 268, 24247-24254 [Abstract/Free Full Text]
  2. Bokoch, G. M., Bickford, K., Bohl, B. P. (1988) J. Cell Biol. 106, 1927-1936 [Abstract/Free Full Text]
  3. Boulay, F., Tardif, M., Brouchon, L., Vignais, P. (1990) Biochem. Biophys. Res. Commun. 168, 1103-1109 [CrossRef][Medline] [Order article via Infotrieve]
  4. Böyum, A. (1968) Scand. J. Clin. Lab. Invest. 97, 77-89
  5. Didsbury, J. R., Uhing, R. J., Tomhave, E., Gerard, C., Gerard, N., Snyderman, R. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 11564-11568 [Abstract/Free Full Text]
  6. Fällman, M., Gullberg, M., Hellberg, C., Andersson, T. (1992) J. Biol. Chem. 267, 2656-2663 [Abstract/Free Full Text]
  7. Gerard, N. P., Gerard, C. (1990) Biochemistry 29, 9274-9281 [CrossRef][Medline] [Order article via Infotrieve]
  8. Janeczek, A. H., Marasco, W. A., Van Alten, P. J., Walter, R. J. (1989) J. Cell Sci. 94, 155-168 [Abstract/Free Full Text]
  9. Jesaitis, A. J. (1992) Comments Mol. Cell Biophys. 8, 97-114
  10. Jesaitis, A. J., Naemura, J. R., Sklar, L. A., Cochrane, C. G., Painter, R. G. (1984) J. Cell Biol. 98, 1378-1387 [Abstract/Free Full Text]
  11. Jesaitis, A. J., Tolley, J. O., Allen, R. A. (1986) J. Biol. Chem. 261, 13662-13669 [Abstract/Free Full Text]
  12. Jesaitis, A. J., Tolley, J. O., Bokoch, G. M., Allen, R. A. (1989) J. Cell Biol. 109, 2783-2790 [Abstract/Free Full Text]
  13. Klotz, K.-N., Jesaitis, A. J. (1994) Biochem. Pharmacol. 48, 1297-1300 [CrossRef][Medline] [Order article via Infotrieve]
  14. Koo, C., Lefkowitz, R. J., Snyderman, R. (1983) J. Clin. Invest. 72, 748-753
  15. Lefkowitz, R. J., Hausdorff, W. P., Caron, M. G. (1990) Trends Pharmacol. Sci. 11, 190-194 [CrossRef][Medline] [Order article via Infotrieve]
  16. McLeish, K. R., Gierschik, P., Jakobs, K. H. (1989) Mol. Pharmacol. 36, 384-390 [Abstract]
  17. Murphy, P. M. (1994) Annu. Rev. Immunol. 12, 593-633 [CrossRef][Medline] [Order article via Infotrieve]
  18. Posner, R. G., Fay, S. P., Domalewski, M. D., Sklar, L. A. (1994) Mol. Pharmacol. 45, 65-73 [Abstract]
  19. Probst, W. C., Snyder, L. A., Schuster, D. I., Brosius, J., Sealfor, S. C. (1992) DNA Cell Biol. 11, 1-20 [Medline] [Order article via Infotrieve]
  20. Prossnitz, E. R., Quehenberger, O., Cochrane, C. G., Ye, R. D. (1993) Biochem. J. 294, 581-587
  21. Prossnitz, E. R., Kim, C. M., Benovic, J. L., Ye, R. D. (1995) J. Biol. Chem. 270, 1130-1137 [Abstract/Free Full Text]
  22. Särndahl, E., Lindroth, M., Bengtsson, T., Fällman, M., Gustavsson, J., Stendahl, O., Andersson, T. (1989) J. Cell Biol. 109, 2791-2799 [Abstract/Free Full Text]
  23. Särndahl, E., Bokoch, G. M., Stendahl, O., Andersson, T. (1993) Proc. Natl. Acad. Sci. U. S. A. 90, 6552-6556 [Abstract/Free Full Text]
  24. Sengeløv, H., Boulay, F., Kjeldsen, L., Borregaard, N. (1994) Biochem. J. 299, 473-479
  25. Showell, H. J., Williams, D., Becher, E. L., Naccache, P. H., Sháafi, R. (1979) J. Reticuloendothel. Soc. 25, 139-150 [Medline] [Order article via Infotrieve]
  26. Sibley, D. R., Lefkowitz, R. J. (1985) Nature 317, 124-129 [CrossRef][Medline] [Order article via Infotrieve]
  27. Sibley, D. R., Strasser, R. H., Caron, M. G., Lefkowitz, R. J. (1985) J. Biol. Chem. 260, 3883-3886 [Abstract/Free Full Text]
  28. Sklar, L. A., Finney, D. A., Oades, Z. G., Jesaitis, A. J., Painter, R. G., Cochrane, C. G. (1984) J. Biol. Chem. 259, 5661-5669 [Abstract/Free Full Text]
  29. Tardif, M., Mery, L., Brouchon, L., Boulay, F. (1993) J. Immunol. 150, 3534-3545 [Abstract]
  30. Wilden, U., Hall, S. W., Kuhn, H. (1986) Proc. Natl. Acad. Sci. U. S. A. 83, 1174-1178 [Abstract/Free Full Text]
  31. Ye, R. D., Prossnitz, E. R., Zou, A. H., Cochrane, C. G. (1991) Biochem. Biophys. Res. Commun. 180, 105-111 [CrossRef][Medline] [Order article via Infotrieve]

©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. I. A. Roach, R. A. Rebres, I. D. C. Fraser, D. L. DeCamp, K.-M. Lin, P. C. Sternweis, M. I. Simon, and W. E. Seaman
Signaling and Cross-talk by C5a and UDP in Macrophages Selectively Use PLC{beta}3 to Regulate Intracellular Free Calcium
J. Biol. Chem., June 20, 2008; 283(25): 17351 - 17361.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Nebl, K. N. Pestonjamasp, J. D. Leszyk, J. L. Crowley, S. W. Oh, and E. J. Luna
Proteomic Analysis of a Detergent-resistant Membrane Skeleton from Neutrophil Plasma Membranes
J. Biol. Chem., November 1, 2002; 277(45): 43399 - 43409.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
W. Bloch, Y. Fan, J. Han, S. Xue, T. Schoneberg, G. Ji, Z. J. Lu, M. Walther, R. Fassler, J. Hescheler, et al.
Disruption of cytoskeletal integrity impairs Gi-mediated signaling due to displacement of Gi proteins
J. Cell Biol., August 20, 2001; 154(4): 753 - 762.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Liu, O. Harbecke, H. Elwing, P. Follin, A. Karlsson, and C. Dahlgren
Desensitization of Formyl Peptide Receptors Is Abolished in Calcium Ionophore-Primed Neutrophils: An Association of the Ligand-Receptor Complex to the Cytoskeleton Is Not Required for a Rapid Termination of the NADPH-Oxidase Response
J. Immunol., March 1, 1998; 160(5): 2463 - 2468.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Zheng, J. Eckerdal, I. Dimitrijevic, and T. Andersson
Chemotactic Peptide-induced Activation of Ras in Human Neutrophils Is Associated with Inhibition of p120-GAP Activity
J. Biol. Chem., September 12, 1997; 272(37): 23448 - 23454.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y.-J. Wang, R. B. Gregory, and G. J. Barritt
Regulation of F-actin and Endoplasmic Reticulum Organization by the Trimeric G-protein Gi2 in Rat Hepatocytes. IMPLICATION FOR THE ACTIVATION OF STORE-OPERATED Ca2+ INFLOW
J. Biol. Chem., July 14, 2000; 275(29): 22229 - 22237.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Särndahl, E.
Right arrow Articles by Andersson, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Särndahl, E.
Right arrow Articles by Andersson, T.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement